Stocktoria

Burning Rock Biotech Ltd BNR

Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2020-06-12
Chart by TradingView
5/9
Piotroski F — financial health
-11.46
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$77.2M$70.7M$75.7M$81.7M$79.7M
Gross profit$57.6M$49.6M$51.2M$55.1M$57.1M
Operating income-$7.8M-$49.0M-$94.3M-$142.1M-$125.1M
Net income-$7.9M-$47.5M-$92.1M-$140.8M-$125.0M
Operating cash flow-$4.1M-$12.6M-$36.0M-$66.2M-$75.0M
Free cash flow-$4.8M-$13.4M-$37.2M-$75.2M-$107.1M
Total assets$117.3M$121.3M$146.5M$230.2M$357.6M
Total liabilities$40.8M$41.7M$38.3M$62.2M$68.0M
Shareholders' equity$76.5M$79.6M$108.2M$167.9M$289.6M
Ratios
Gross margin74.7%70.3%67.6%67.5%71.7%
Operating margin-10.2%-69.3%-124.5%-174.1%-156.9%
Net margin-10.3%-67.2%-121.6%-172.4%-156.9%
FCF margin-6.2%-18.9%-49.1%-92.1%-134.3%
Return on assets-6.7%-39.2%-62.9%-61.2%-35.0%
Return on equity-10.3%-59.7%-85.1%-83.8%-43.2%
Current ratio2.992.923.363.064.89
Revenue growth9.2%-6.6%-7.3%2.5%21.0%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC35,407$571,115

Why these scores methodology →

Piotroski F-score: 5/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -11.46 (distress)

  • Working capital / assets 0.599
  • Retained earnings / assets -5.187
  • EBIT / assets -0.067
  • Equity / liabilities 1.877

Sector peers

GOOG · MSFT · META · BABA · DIS · HCA · all Services →

Source: SEC EDGAR filings · CIK 0001792267 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.